Keratin 17: a useful marker in anti-psoriatic therapies.
de Jong
E M
EM
Department of Dermatology, University Hospital Nijmegen, The Netherlands.
van Vlijmen
I M
IM
van Erp
P E
PE
Ramaekers
F C
FC
Troyanovski
S M
SM
van de Kerkhof
P C
PC
D000875:Anthralin / Q000592:standards / Q000627:therapeutic use; D000911:Antibodies, Monoclonal; D015415:Biomarkers / Q000737:chemistry; D002117:Calcitriol / Q000031:analogs & derivatives / Q000592:standards / Q000627:therapeutic use; D005629:Frozen Sections; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D007150:Immunohistochemistry; D007633:Keratins / Q000032:analysis* / Q000235:genetics / Q000378:metabolism; D011565:Psoriasis / Q000188:drug therapy / Q000378:metabolism*; D012867:Skin / Q000737:chemistry
D000911:Antibodies, Monoclonal; D015415:Biomarkers; C055085:calcipotriene; D007633:Keratins; D002117:Calcitriol; D000875:Anthralin